Hongyan Zhang

Anhui Provincial Hospital

Hefei

China

SCHOLARLY PAPERS

2

DOWNLOADS

42

TOTAL CITATIONS

5

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Multicentre Randomised Phase III Trial of Capecitabine With or Without Irinotecan Guided by UGT1A1 Status in Patients Undergoing Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

Number of pages: 45 Posted: 20 Mar 2020
Ji Zhu, Anwen Liu, Xinchen Sun, Luying Liu, Yaqun Zhu, Tao Zhang, Jianhui Jia, Shisheng Tan, Junxin Wu, Xin Wang, Juying Zhou, Jialin Yang, Chen Zhang, Hongyan Zhang, Yuanyuan Zhao, Gan Cai, Fan Xia, Juefeng Wan, Hui Zhang, Lijun Shen, Sanjun Cai and Zhen Zhang
Fudan University - Department of Radiation Oncology, Nanchang University - Department of Radiation Oncology, Nanjing Medical University - Department of Radiation Oncology, Chinese Academy of Sciences (CAS) - Department of Radiation Oncology, Soochow University - Department of Radiation Oncology, Chongqing Medical University - Department of Oncology, China Medical University - Department of Radiotherapy, Guizhou Provincial People's Hospital - Department of Oncology, Fujian Medical University - Department of Radiation Oncology, affiliation not provided to SSRN, Soochow University - Department of Radiation Oncology, University of Electronic Science and Technology of China (UESTC) - Department of Radiation Oncology, Chinese Academy of Sciences (CAS) - Department of Radiation Oncology, Anhui Provincial Hospital, Qingdao University, Shanghai Jiao Tong University (SJTU), School of Medicine, Ruijin Hospital, Department of Radiation Oncology, Fudan University - Department of Radiation Oncology, Fudan University - Department of Radiation Oncology, Fudan University - Department of Radiation Oncology, Fudan University - Department of Radiation Oncology, Fudan University - Department of Colorectal Surgery and Fudan University - Department of Radiation Oncology
Downloads 28 (958,996)
Citation 4

Abstract:

Loading...

2.

Concurrent Chemoradiotherapy with Extended Nodal Irradiation and/or Erlotinib in Locally Advanced Esophageal Squamous Cell Cancer: Long-Term Follow-Up of a Randomized Phase 3 Trial

Number of pages: 64 Posted: 07 Jun 2019
Congying Xie, Zhao Jing, Honglei Luo, Wei Hu, Anping Zheng, Duojie Li, Lingyu Ding, Hongyan Zhang, Conghua Xie, Xilong Lian, Dexi Du, Ming Chen, Xiuhua Bian, Bangxian Tan, Bing Xia, Ni Zhang, Ruifei Xie, Qing Liu, Lvhua Wang and Shixiu Wu
Wenzhou Medical University - Second Affiliated Hospital, Hangzhou Cancer Hospital - Department of Radiation Oncology, The First People’s Hospital of Huaihua, Wenzhou Medical University - Taizhou Hospital of Zhejiang Province, Chinese Academy of Sciences (CAS) - Department of Radiation Oncology, Bengbu Medical College - First Affiliated Hospital, Hangzhou Cancer Hospital, Anhui Provincial Hospital, Wuhan University - Department of Radiation and Medical Oncology, Kaohsiung Medical University - Kaohsiung Medical University Hospital, Central Hospital of Lishui City, Chinese Academy of Sciences (CAS) - Department of Radiation Oncology, Jiangsu Cancer Hospital, North Sichuan Medical College - First Affiliated Hospital, Hangzhou Cancer Hospital - Department of Radiation Oncology, Hangzhou Cancer Hospital - Department of Radiation Oncology, Hangzhou Cancer Hospital - Information Center, Sun Yat-sen University (SYSU), Chinese Academy of Medical Sciences - National Cancer Center and Hangzhou Cancer Hospital - Hangzhou Cancer Institute
Downloads 14 (1,118,726)
Citation 1

Abstract:

Loading...

esophageal squamous cell cancer, elective nodal irradiation, erlotinib